TickerFacts.

Dexcom Inc (DXCM): Total Assets

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$6.34B
As of 2025-12-31
$6.46B
As of 2026-06-30
+5.5%
3-year compound annual growth
$6.48B2010-12-31: $77.16M2011-12-31: $120.50M2012-12-31: $106.00M2013-12-31: $122.50M2014-12-31: $184.60M2015-12-31: $292.00M2016-12-31: $402.80M2017-12-31: $904.10M2018-12-31: $1.92B2019-12-31: $2.40B2020-12-31: $4.29B2021-12-31: $4.93B2022-12-31: $5.39B2023-12-31: $6.26B2024-12-31: $6.48B2025-12-31: $6.34B$6.34B
2010-12-31 Total Assets (USD) 2025-12-31
Period endedTotal AssetsChange YoYSource filing
2025-12-31$6.34B-2.2%2026-02-12, Balance as of period end
2024-12-31$6.48B+3.5%2026-02-12, Balance as of period end
2023-12-31$6.26B+16.2%2025-02-18, Balance as of period end
2022-12-31$5.39B+9.3%2024-02-08, Balance as of period end
2021-12-31$4.93Bn/c2023-02-09, Balance as of period end
2020-12-31$4.29B+79.1%2022-02-14, Balance as of period end
2019-12-31$2.40B+25.0%2021-02-11, Balance as of period end
2018-12-31$1.92B+111.9%2020-02-13, Balance as of period end
2017-12-31$904.10M+124.5%2019-02-21, Balance as of period end
2016-12-31$402.80M+37.9%2018-02-27, Balance as of period end
2015-12-31$292.00M+58.2%2017-02-28, Balance as of period end
2014-12-31$184.60M+50.7%2016-02-23, Balance as of period end
2013-12-31$122.50M+15.6%2015-02-25, Balance as of period end
2012-12-31$106.00M-12.0%2014-02-20, Balance as of period end
2011-12-31$120.50M+56.2%2013-02-21, Balance as of period end
2010-12-31$77.16Mn/a2012-02-23, Balance as of period end

Total Assets at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedTotal AssetsChange YoY
Dexcom Inc (DXCM)2025-12-31$6.34B-2.2%
ResMed Inc (RMD)2026-06-30$8.97B+9.7%
MiniMed Group, Inc. (MMED)2026-04-24$4.63B+10.2%
West Pharmaceutical Services Inc (WST)2025-12-31$4.27B+17.2%
Globus Medical Inc (GMED)2025-12-31$5.30B+1.0%
Insulet Corp (PODD)2025-12-31$3.19B+3.3%
Solventum Corp (SOLV)2025-12-31$14.29B-1.1%
ICU Medical Inc (ICUI)2025-12-31$4.05B-3.6%
Teleflex Inc (TFX)2025-12-31$6.95B-2.1%

Compare DXCM, RMD, MMED, WST side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗